The "Ped. ALL Panel - Karyotyping and MLPA Deletion/Duplication and FISH Panel Test" is a comprehensive genetic testing panel designed for pediatric patients diagnosed with Acute Lymphoblastic Leukemia (ALL). This advanced diagnostic test, available at DNA Labs UAE, combines several genetic testing methodologies to provide a thorough analysis of chromosomal abnormalities and genetic mutations associated with ALL.
The panel includes:
1. **Karyotyping**: This method involves analyzing the chromosome structure to identify any large-scale genetic alterations, such as translocations, deletions, or duplications that are often associated with different forms of leukemia.
2. **MLPA (Multiplex Ligation-dependent Probe Amplification)**: MLPA is used to detect smaller deletions and duplications in the genes that may not be visible through karyotyping. This technique is crucial for identifying specific genetic changes that can influence treatment decisions and prognosis.
3. **FISH (Fluorescence In Situ Hybridization) Panel Test**: FISH allows for the visualization of genetic abnormalities at a more detailed level. It is particularly useful for detecting specific gene rearrangements known to occur in ALL.
This panel is a vital tool in the personalized medicine approach for treating pediatric ALL, enabling healthcare professionals to tailor treatment plans based on the specific genetic profile of the leukemia. The test is priced at 4800 AED and is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. By providing a comprehensive genetic overview, the Ped. ALL Panel aids in the prognosis, helps in determining the risk of relapse, and guides in the selection of the most effective treatment strategies for young patients.
The HLA Pre-Transplant Workup Panel 2 Test is a critical diagnostic tool used in the preparation for organ and tissue transplantation. This comprehensive test is performed to ensure compatibility between the donor and recipient, thereby reducing the risk of transplant rejection. HLA, or Human Leukocyte Antigen, testing is crucial for identifying the specific antigens on the surface of cells that can trigger an immune response in the recipient's body.
Performed at DNA Labs UAE, a facility renowned for its advanced diagnostic services, the HLA Pre-Transplant Workup Panel 2 Test involves a series of sophisticated assays to analyze the HLA genes of both donor and recipient. This test is pivotal in matching organ donors with recipients in transplant medicine, making it an indispensable part of the pre-transplant evaluation process.
The cost of the HLA Pre-Transplant Workup Panel 2 Test at DNA Labs UAE is 4800 AED. This investment is crucial for the success of transplant procedures, as it significantly increases the chances of compatibility, thereby enhancing the long-term outcomes for transplant recipients. With its state-of-the-art technology and expert team, DNA Labs UAE ensures precise and reliable results, providing a solid foundation for successful transplantation.
The "Nx Gen Sequencing Albinism Test" is a state-of-the-art genetic test offered by DNA Labs UAE, designed to accurately diagnose albinism, a group of genetic disorders characterized by a lack of melanin pigment in the skin, hair, and eyes. Utilizing Next Generation Sequencing (NGS) technology, this test can identify mutations in the specific genes known to cause albinism, providing a comprehensive analysis of the genetic markers associated with this condition. With a cost of 5730 AED, the test offers a reliable solution for individuals seeking a definitive diagnosis, enabling them to understand their condition better and seek appropriate treatment and management. DNA Labs UAE ensures precision, confidentiality, and support throughout the testing process, making it a trusted choice for genetic testing in the region.
The "Nx Gen Sequencing Cataract Test" is a cutting-edge diagnostic tool available at DNA Labs UAE, designed to provide comprehensive insights into the genetic predisposition of individuals to cataracts. Utilizing Next-Generation Sequencing (NGS) technology, this test examines a person's DNA to identify specific genetic variations that could indicate a higher risk of developing cataracts. Cataracts are a leading cause of vision impairment and blindness worldwide, characterized by the clouding of the eye's natural lens. Early detection through genetic testing can empower individuals with valuable information to take proactive steps in monitoring and managing their eye health. The test is priced at 5730 AED, reflecting the advanced technology and the detailed analysis provided. DNA Labs UAE, known for its state-of-the-art facilities and expert staff, ensures a reliable and efficient testing process, making it a valuable resource for those seeking to understand their genetic risk for cataracts.
The "Nx Gen Sequencing Corneal Dystrophy Test" offered by DNA Labs UAE is a sophisticated diagnostic tool designed to identify genetic mutations associated with various types of corneal dystrophies. Corneal dystrophies are a group of inherited eye disorders that affect the cornea, the clear front surface of the eye, leading to visual impairment or vision loss. This test employs Next-Generation Sequencing (NGS) technology, a cutting-edge approach that allows for the comprehensive analysis of multiple genes simultaneously with high accuracy and speed. By pinpointing specific genetic mutations, the test provides crucial information that can aid in the accurate diagnosis, personalized treatment planning, and genetic counseling for affected individuals and their families. The cost of the test is 5730 AED, reflecting the advanced technology and expertise required to perform this detailed genetic analysis. Conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services, the Nx Gen Sequencing Corneal Dystrophy Test represents a significant advancement in the field of ophthalmic genetics and personalized medicine.
The "Nx Gen Sequencing Glaucoma Test" offered by DNA Labs UAE represents a cutting-edge approach in the early detection and management of glaucoma, a group of eye conditions that can lead to vision loss by damaging the optic nerve, often associated with increased pressure within the eye. Utilizing next-generation sequencing (NGS) technology, this test analyzes multiple genes known to be linked with the development of glaucoma. By examining an individual's genetic predisposition, the test provides valuable insights into the risk factors, helping in the formulation of personalized prevention and treatment plans.
The cost of the Nx Gen Sequencing Glaucoma Test is 5730 AED. This investment allows patients to access a comprehensive analysis of their genetic makeup with respect to glaucoma, enabling early intervention strategies that can significantly alter the course of the disease. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test stands as a testament to the advancements in genetic research and its application in enhancing patient care in ophthalmology.
The "Nx Gen Sequencing Hereditary Retinoblastoma Test" is a cutting-edge genetic test offered by DNA Labs UAE, designed to identify mutations in genes associated with hereditary retinoblastoma, a rare type of eye cancer that predominantly affects young children. This test utilizes next-generation sequencing (NGS) technology, enabling a comprehensive analysis of the genome to detect genetic variations that may increase the risk of developing retinoblastoma. With a focus on precision and accuracy, this test is crucial for early detection and management of the condition, allowing for timely intervention and improved outcomes. The cost of the test is set at 5730 AED, reflecting the sophisticated technology and expertise required to perform the analysis. By opting for this test, individuals can gain valuable insights into their genetic predisposition to retinoblastoma, facilitating informed decisions regarding their health and the health of their family members.
Leber Congenital Amaurosis (LCA) is a genetic disorder that leads to severe vision loss or blindness at birth or within the first few months of life. To provide a precise diagnosis and potentially guide treatment options, the Nx Gen Sequencing Leber Congenital Amaurosis Test is offered by DNA Labs UAE. This advanced genetic test utilizes next-generation sequencing (NGS) technology to analyze the specific genes known to be associated with LCA, allowing for the identification of mutations that may be responsible for the condition in affected individuals.
The test is priced at 5730 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, which is equipped with the latest in genetic testing technology. By pinpointing the exact genetic mutations present, this test not only facilitates an accurate diagnosis but also helps in understanding the inheritance patterns of the disorder, which is crucial for affected families considering future pregnancies. Moreover, with the rapid advancements in gene therapy and other treatments, identifying the specific genetic cause of LCA can open up new avenues for personalized treatment plans.
The Nx Gen Sequencing Microphthalmia Anophthalmia Coloboma Spectrum Test is a comprehensive genetic screening designed to diagnose conditions within the spectrum of eye development disorders, including microphthalmia (small eye), anophthalmia (absence of one or both eyes), and coloboma (missing pieces of tissue in structures that form the eye). Utilizing next-generation sequencing (NGS) technology, this test can identify mutations in the genes known to be associated with these conditions, offering insights into the genetic cause of the disorder in affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test aims to provide crucial information for diagnosis, management, and genetic counseling for families affected by these conditions. With a cost of 5730 AED, the test represents an investment in understanding the genetic underpinnings of these eye development disorders, potentially guiding treatment options and supporting research into new therapies. This test is particularly valuable for families seeking answers about the genetic basis of these conditions and for healthcare professionals involved in the care of patients with visual impairments due to developmental eye disorders.
The Nx Gen Sequencing Ophthalmoplegia Test is a cutting-edge diagnostic procedure available at DNA Labs UAE, designed to identify genetic markers associated with ophthalmoplegia, a condition characterized by weakness or paralysis of the eye muscles. This sophisticated test leverages Next Generation Sequencing (NGS) technology to analyze multiple genes simultaneously, providing comprehensive insights into the genetic underpinnings of this condition. With a cost of 5730 AED, the test offers a thorough examination of the patient's DNA to pinpoint mutations that could lead to ophthalmoplegia, aiding in the accurate diagnosis and facilitating tailored treatment plans for affected individuals. By choosing DNA Labs UAE for this test, patients can expect reliable, precise, and swift genetic analysis in their quest for answers and management strategies for ophthalmoplegia.
